Moulin By Jean-Paul
MONSIEUR TOUTON SELECTION, LTD. — NEW YORK, NY
France
About Moulin By Jean-Paul
Moulin By Jean-Paul is a vodka produced in France and bottled at 80 to 89 proof. The brand holds one approved label registration with the U.S. Alcohol and Tobacco Tax and Trade Bureau, indicating its entry into the American market. According to TTB records, the brand's most recent approval activity occurred in 2026. The vodka represents a single distinct product offering within its category. As a French vodka in the standard proof range, Moulin By Jean-Paul occupies a position within the broader vodka market that emphasizes European production. The brand's regulatory standing demonstrates compliance with federal spirits labeling requirements for spirits imported into the United States. Details regarding production methods, ingredients, or specific marketing positioning are not part of the publicly available TTB registration data for this product.
| Label Name | Spirit Type | Status | Approval Date | Producer | |
|---|---|---|---|---|---|
 | Moulin By Jean-Paul VODKA 80-89 PROOF FB | Vodka 80-89 Proof Fb | Approved | 2026-03-23 | MONSIEUR TOUTON SELECTION, LTD. |
Page 1 of 1
Moulin By Jean-Paul at a Glance
Moulin By Jean-Paul has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof Fb. Labels approved between 2026-03-23 and 2026-03-23. Produced in France.
All information sourced from public TTB records.
Are you the owner or distributor of Moulin By Jean-Paul?
Claim this brand listing to update information or get featured. Contact team@buy.vodka.
Produced At
Monsieur Touton Selection, LTD.Related Brands
- Grey Goose also from France
- Mont Blanc also from France
- Gallant also from France
- Kelt also from France
- Gaison also from France
- Svedka also makes Vodka 80-89 Proof Fb
- Stoli also makes Vodka 80-89 Proof Fb
- Stolichnaya also makes Vodka 80-89 Proof Fb
- Van Gogh also makes Vodka 80-89 Proof Fb
- Beluga also makes Vodka 80-89 Proof Fb
Related Questions
Browse All Labels
Stay informed
Newsletter coming soon.
Follow us on X for new approvals, launches, and industry intelligence.